Table 1 Key echocardiographic outcomes in the MI subgroups.
7 Days | 30 Days | |||
|---|---|---|---|---|
MI + SSO2 (N = 5) | MI + Sham (N = 5) | MI + SSO2 (N = 5) | MI + Sham (N = 5) | |
Baseline EF | 58.1 ± 2.6% | 55.9 ± 3.8% | 56.2 ± 5.9% | 54.6 ± 2.3% |
Post-MI EF | 34.5 ± 12.4% | 36.1 ± 3.6% | 38.2 ± 4.6% | 35.3 ± 2.2% |
Post-Infusion EF | 38.9 ± 10.9% | 38.8 ± 5.2% | 41.4 ± 5.0% | 36.5 ± 4.8% |
Terminal EF | 55.9 ± 2.5% | 55.5 ± 4.0% | 50.9 ± 4.0% | 46.6 ± 1.9% |
Terminal Anterior Wall Motion Score Index | 1.30 ± 0.18 | 1.37 ± 0.46 | 1.40 ± 0.22 | 1.20 ± 0.21 |
